Cargando…

OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?

Brown adipose tissue (BAT) activation after cold exposure and its subsequent detection via18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) is mediated through norepinephrine (NE) induced β3-adrenoceptor activation. Pheochromocytoma/paragangliomas (PPGLs), espe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdul Sater, Zahraa, Jha, Abhishek, Hamimi, Ahmed, Mandl, Adel, Hartley, Iris, Gubbi, Sriram, Gonzales, Melissa, Gharib, Ahmed, Pacak, Karel, Cypess, Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555004/ http://dx.doi.org/10.1210/js.2019-OR29-6

Ejemplares similares

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

MON-214 Biochemical Abnormalities in Endocrine Function Associated with Lutetium 177-DOTATATE Therapy in Metastatic Pheochromocytoma and Paraganglioma
por: Gubbi, Sriram, et al.
Publicado: (2020)

PSUN27 Largest Cohort of Cervical Spine Metastases of Pheochromocytoma/Paraganglioma in the Setting of SDHB Mutation
por: Pacak, Karel, et al.
Publicado: (2022)

Model systems in SDHx-related pheochromocytoma/paraganglioma
por: Takács-Vellai, Krisztina, et al.
Publicado: (2021)

OR29-4 Pregnancy Outcomes in Women with Pheochromocytoma and Paraganglioma: An International Multi-Center Study
por: Bancos, Irina, et al.
Publicado: (2019)

MON-199 Targeting Pheochromocytoma/Paraganglioma with Polyamine Inhibitors
por: Ghayee, Hans Kumar, et al.
Publicado: (2020)

Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2021)

The Improvement in Hepatic Steatosis After Cushing’s Syndrome Treatment Is an Early Sign of Metabolic Recovery
por: Hamimi, Ahmed, et al.
Publicado: (2021)

Novel Germline SUCLG2 Mutations in Patients With Pheochromocytoma and Paraganglioma
por: Vanova, Katerina Hadrava, et al.
Publicado: (2021)

Mutational Profile of Metastatic Pheochromocytoma and Paraganglioma
por: Choi, Yun Mi, et al.
Publicado: (2021)

Using Multimodal Functional Imaging in the Management of SDHx-Related Pheochromocytoma and Paraganglioma
por: White, Gemma, et al.
Publicado: (2021)

MON-218 Clinical and Genetic Aspects of Pediatric Pheochromocytomas and Paragangliomas
por: Petenuci, Janaina, et al.
Publicado: (2020)

MON-204 Pheochromocytoma and Paraganglioma: An Emerging Cause of Secondary Osteoporosis
por: Yokomoto-Umakoshi, Maki, et al.
Publicado: (2020)

SAT305 Clinical Characteristics And Outcomes Of Patient With Metastatic Pheochromocytoma/Paraganglioma (PPGL) And Extreme Elevated Biochemistry
por: Prodanov, Tamara, et al.
Publicado: (2023)

ODP032 Case Series: Prazosin in the Preoperative Management of Pheochromocytoma and Paraganglioma
por: Barreiro, Margarita, et al.
Publicado: (2022)

SUN-344 SDHB Immunostaining: Still an Indispensable Tool in Characterising Pheochromocytoma and Paraganglioma
por: Velusamy, Anand, et al.
Publicado: (2019)

RF33 | PSUN03 Rates of Pheochromocytoma/Paraganglioma Screening in At-Risk Populations
por: Grigoryan, Seda, et al.
Publicado: (2022)

MON-377 Hereditary Paraganglioma Pheochromocytoma Syndrome in the Setting of End Stage Renal Disease
por: Harty, Roger
Publicado: (2019)

Tumor Detection Rates in Screening of Individuals with SDHx-related Hereditary Paraganglioma-Pheochromocytoma Syndrome
por: Greenberg, Samantha E., et al.
Publicado: (2020)

MON-383 Sporadic Bilateral Pheochromocytoma with Renal Pelvis Paraganglioma: A Rare Coexisting Occurrence
por: Pirela, Daniela, et al.
Publicado: (2019)

MON-195 Genetic Analysis and Clinical Characteristics of Hereditary Paraganglioma and Pheochromocytoma Syndrome in Korean Population
por: Choi, Heewon, et al.
Publicado: (2020)

PSAT089 Lack of Effect of Metformin in Murine Pheochromocytoma Model
por: Ghayee, Hans K, et al.
Publicado: (2022)

MON-385 Malignant Pheochromocytoma/Paraganglioma Syndrome during Pregnancy: Clinical Case Report, a Therapeutic Challenge
por: Sanchez, Pedro, et al.
Publicado: (2019)

MON-196 A Single-Center Experience of Patients with Metastatic Pheochromocytoma/Paraganglioma Treated with (177)Lu-DOTATATE
por: Roslyakova, Anna, et al.
Publicado: (2020)

Changes in Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A Four-Decade Experience in a Academic Center
por: Uslar, Thomas, et al.
Publicado: (2021)

RF21 | PSUN08 Morphologic or Molecular Imaging - Diagnostic Capabilities in von Hippel-Lindau related pheochromocytoma
por: Patel, Mayank, et al.
Publicado: (2022)

Mediastinal paragangliomas related to SDHx gene mutations
por: Michałowska, Ilona, et al.
Publicado: (2016)

A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
por: Kolasinska-Ćwikła, Agnieszka, et al.
Publicado: (2019)

A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas
por: Imperiale, Alessio, et al.
Publicado: (2013)

Preoperative Amlodipine Is More Efficacious Than Prazosin in Preventing Intraoperative Haemodynamic Instability in Pheochromocytoma/Paraganglioma Patients: Interim Analysis of a Pilot Randomized Controlled Study
por: Memon, Saba Samad, et al.
Publicado: (2021)

RF09 | PSUN29 Evidence for a Founder Effect of SDHB Exon 1 Complete Deletion in Brazilian Patients with Paraganglioma
por: Fagundes, Gustavo F, et al.
Publicado: (2022)

Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas
por: Snezhkina, Anastasiya V., et al.
Publicado: (2020)

OR12-5 | LBSAT57 Long-term Follow-Up of Pheochromocytoma/Paraganglioma (PPGL) after first diagnosis: a retrospective single-center study of 173 patients
por: Krall, Christoph, et al.
Publicado: (2022)

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

SAT308 An Assessment Of Prognostic Markers To Predict Metastatic Pheochromocytoma/Paraganglioma
por: Lundholm, Michelle D, et al.
Publicado: (2023)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

SUN-347 Measurement of Plasma and Urine Metanephrines in the Setting of Hypertensive Emergency: Is There a Clinical Utility?
por: Gubbi, Sriram, et al.
Publicado: (2019)

MON-212 Genetic Spectrum Of A Canadian Cohort Of Sporadic Pheochromocytomas And Paragangliomas: Higher Prevalence Of Germline Mutations In PGL And NGS Assay With A Multigene Panel Increases The Mutation Rate
por: Salle, Stefanie Parisien-La, et al.
Publicado: (2020)

Pheochromocytoma and Takotsubo Syndrome: An Ominous Duo
por: Yalta, Kenan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2qejsj10486gigt6s2l0chgrha